(Q34699154)

4 August 2017

title

Prediction of genetic risk for dyslipidemia (English)

1 reference

4 August 2017

1 reference

16

Yoshinori Nozawa

1 reference

4 August 2017

5

Kimihiko Kato

1 reference

4 August 2017

Yoshiji Yamada

1

1 reference

4 August 2017

Hitoshi Matsuo

2

1 reference

4 August 2017

Shunichiro Warita

3

1 reference

4 August 2017

Sachiro Watanabe

4

1 reference

4 August 2017

Mitsutoshi Oguri

6

1 reference

4 August 2017

Kiyoshi Yokoi

7

1 reference

4 August 2017

Norifumi Metoki

8

1 reference

4 August 2017

Hidemi Yoshida

9

1 reference

4 August 2017

Kei Satoh

10

1 reference

4 August 2017

Sahoko Ichihara

11

1 reference

4 August 2017

Yukitoshi Aoyagi

12

1 reference

4 August 2017

Akitomo Yasunaga

13

1 reference

4 August 2017

Hyuntae Park

14

1 reference

4 August 2017

Masashi Tanaka

15

1 reference

4 August 2017

publication date

4 October 2007

1 reference

4 August 2017

1 reference

4 August 2017

volume

90

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

551-558

1 reference

Nutrigenetics, plasma lipids, and cardiovascular risk

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Meta-analysis of four new genome scans for lipid parameters and analysis of positional candidates in positive linkage regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Meta-analysis of genome-wide linkage studies for quantitative lipid traits in African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Genome-wide linkage scans for loci affecting total cholesterol, HDL-C, and triglycerides: the Family Blood Pressure Program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

The apoAI-CIII-AIV gene cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

APOA5polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Structure and interfacial properties of human apolipoprotein A-V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Lipoprotein Lipase Activity Is Associated With Severity of Angina Pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Low-density lipoprotein cholesterol can be chemically measured: a new superior method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2007.08.001

10.1016/J.YGENO.2007.08.001

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference